2 / 20
Page 16
Notes:
J Parasit Dis Diagn Ther 2017 | Volume 2 Issue 4
allied
academies
International Conference on
Zoology, Microbiology & Medical Parasitology
October 30-November 01, 2017 | Chicago, USA
A
picomplexan are sophisticated cosmopolitan organisms to
include
Toxoplasma
and
Coccidia
which cause important
infectious foodborne diseases in humans and animals.
Toxoplasma
is ubiquitous and invades every nucleated cells
and organs with severe life threatening systemic inflammation
in fetal, neonatal and immune-compromised individuals.
Coccidias are highly host specific mainly lodge in gut mucosa
and compromise immune system to trigger gastrointestinal
inflammatory complications and infectious diarrhea. Similarly,
Toxoplasma
sexual stage is specific in defensive host to cat
gut mucosa, with coccidian life cycle. Over century after
their discovery, yet there is no safe and effective preventive
measure or vaccines available. Coccidosis is one of the most
important communicable pathogenic diseases resulting in
morbidity and mortality in food animal industry. The common
practice includes the use of antibiotic additives in poultry and
livestock diets which contaminate eggs, milk, bones and meat
production. Antibiotics can enter the food chain and consumed
by humans with possible allergic, antibiotic resistance, and
other yet unknown side effects. For instance, robust and
balance gut microbiota are required to support health and
growth. Application of continuous antibiotics can alter this
delicate balance in digestive tract to promote dysbiosis and
the state of disease. The annual cost of coccidiosis in poultry
production alone has been estimated $800 million in USA.
There is an urgent need for appropriate preventives to abolish
Coccidiosis and Toxoplasmosis endemic. This workshop
presentation will scrutinize Toxoplasmosis and Coccidiosis and
novel therapeutics and possible preventivemodalities including
altered aberrant organisms which are proven nonpathogenic
in immunosuppressed yet immunogenic in immune-intact
animals as a model to protect against the infectious disease.
Speaker Biography
Helieh S Oz has DVM, and MS (U. IL); PhD (U. MN) and clinical translational research
certificate (U. KY Med Center). Dr Oz is an active member of American Association
of Gastroenterology (AGA) and AGA Fellow (AGAF). Dr Oz is Microbiologist scientist
with expertise in infectious and inflammatory diseases, drug discoveries, pathogenesis,
innate and mucosal Immunity, molecular biology, and micronutrient. Dr Oz has over
90 publications in areas of chronic inflammatory disorders (e.g. pancreatitis, hepatitis,
colitis), microbial and infectious diseases (e.g. Toxoplasmosis, Trypanosomasis,
Babesiosis, Coccidiosis,
Pneumocystis
pneumonia). She has served as Lead editor
for special issues including Gut Inflammatory, Infectious diseases and Nutrition 2017
(Mediators of Inflammation); Nutrients, Infectious and Inflammatory Diseases 2017
(Nutrients); Gastrointestinal Inflammation and Repair: Role of Microbiome, Infection,
Nutrition 2016 (Gastroenterology Research Practice), and co-editor for Parasitic
infections in pediatric clinical practice 2017 (J Pediatric Infectious Disease), Chagas
Disease, Intech Open Science 2017 and member of different advisory committees.
e:
hoz2@email.uky.eduHelieh S Oz
UK Medical Center, USA
Urgency for appropriate preventives to abolish Coccidiosis and Toxoplasmosis
endemic: Never ending dilemma and possible alternatives